Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MME | P08473 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.36 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | ECE1 | P42892 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29211036 | 1.00 | TGFBR1 (0.41) | TGFBR1POLBKDM4EMAPTTHRB | |
| Hydrochloric Acid SCHEMBL8615755 | 0.98 | TGFBR1 (0.39) | TGFBR1POLBKDM4EMAPTTHRB | |
| Sulfuric Acid SCHEMBL28677593 | 0.92 | TGFBR1 (0.40) | TGFBR1POLBKDM4EMAPTTHRB | |
| SCHEMBL11846220 | 0.86 | ITGB3 (0.40) | POLBMMEECE1 | |
| SCHEMBL5683578 | 0.84 | CA1 (0.34) | ECE1ACE | |
| SCHEMBL4320263 | 0.84 | CA1 (0.34) | ECE1ACE | |
| SCHEMBL21045069 | 0.83 | TGFBR1 (0.31) | TGFBR1 | |
| SCHEMBL30678658 | 0.83 | FPR2 (0.44) | TGFBR1MMEFOLH1NAALAD2SLC1A3 | |
| SCHEMBL2107300 | 0.83 | FPR2 (0.44) | TGFBR1MMEFOLH1NAALAD2SLC1A3 | |
| SCHEMBL5475677 | 0.82 | CAD (0.44) | TGFBR1POLBKDM4EMAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024254556-A9 | BACTERIAL COMPOSITIONS FOR METABOLIZING UREMIC TOXINS | ATOSSA THERAPEUTICS, INC. (US) | 2025-01-30 | — | — | WO | claimed |
| WO-2024254556-A1 | BACTERIAL COMPOSITIONS FOR METABOLIZING UREMIC TOXINS | ATOSSA THERAPEUTICS, INC. (US) | 2024-12-12 | — | — | WO | claimed |
| WO-2024064579-A1 | IMMUNOGENIC PROTEINS FROM BORDETELLA PERTUSSIS | OHIO STATE INNOVATION FOUNDATION (US) | 2024-03-28 | — | — | WO | claimed |
| WO-2023288050-A9 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2024-03-28 | — | — | WO | claimed |
| CN-117653754-A | Cationic ultrasonic microbubble contrast agent and preparation method thereof | 上海市第六人民医院 | 2024-03-08 | — | — | CN | claimed |
| US-20240019436-A1 | BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS | ABERYSTWYTH UNIVERSITY (GB) | 2024-01-18 | — | — | US | claimed |
| EP-4252004-A1 | BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS | Aberystwyth University (GB) | 2023-10-04 | — | — | EP | claimed |
| WO-2022112763-A1 | BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS | ABERYSTWYTH UNIVERSITY (GB) | 2022-06-02 | — | — | WO | claimed |
| CN-111621267-B | Environment-friendly hyperbranched poly-guano acid shale intercalation inhibitor | 西南石油大学 | 2022-04-01 | — | — | CN | claimed |
| WO-2021062048-A2 | METHODS AND SYSTEMS FOR MODULATING HEPATIC GABA PRODUCTION OR RELEASE TO ALTER FOOD INTAKE IN MONOGASTRIC SPECIES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-04-01 | — | — | WO | claimed |
| US-7262168-B2 | Compositions providing for increased IGF-I solubility | CHIRON CORPORATION (US) | 2007-08-28 | — | — | US | claimed |
| US-20060074011-A1 | Compositions providing for increased IGF-I solubility | CHIRON CORPORATION (US) | 2006-04-06 | — | — | US | claimed |
| US-6951842-B2 | Compositions providing for increased IGF-I solubility | CHIRON CORPORATION (US) | 2005-10-04 | — | — | US | claimed |
| EP-0458949-B1 | STABILIZATION OF K1K2P PRO | BOEHRINGER MANNHEIM GMBH (DE) | 1995-05-03 | — | — | EP | claimed |
| US-5409699-A | Stable, soluble preparations containing sodium citrate and selected compounds | BOEHRINGER MANNHEIM GMBH (DE) | 1995-04-25 | — | — | US | claimed |
| US-5352452-A | Anticoagulants, enzyme activity | BOEHRINGER MANNHEIM GMBH (DE) | 1994-10-04 | — | — | US | claimed |
| US-5352453-A | Acidic ph | BOEHRINGER MANNHEIM GMBH (DE) | 1994-10-04 | — | — | US | claimed |
| EP-0458939-B1 | STABILIZATION OF t-PA pro | BOEHRINGER MANNHEIM GMBH (DE) | 1994-03-23 | — | — | EP | claimed |
| EP-0458930-B1 | STABILIZATION OF GLYCOSYLIZED t-PA | BOEHRINGER MANNHEIM GMBH (DE) | 1993-10-20 | — | — | EP | claimed |
| EP-0458950-B1 | STABILIZATION OF K2P PRO | Roche Diagnostics GmbH (DE) | 1993-09-15 | — | — | EP | claimed |